Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Cell Mater ; 35: 195-208, 2018 03 28.
Artigo em Inglês | MEDLINE | ID: mdl-29589649

RESUMO

Non-viral gene delivery is a safe technique to release sustained physiologic dosages of bone morphogenetic protein (BMP). Co-delivery of multiple BMPs can result in the formation of more potent BMP heterodimers. In this study, non-viral co-delivery of BMP-2/6 and BMP-2/7, as a mean to produce heterodimers, was assessed. Goat MSCs were non-virally transfected with plasmid DNA encoding BMP isoforms (pBMP) known to be relevant for osteogenesis: BMP-2, -6 or -7. As a result, BMP-2, -6 and -7 were produced and detectable for up to 14 d and their combined delivery (pBMP-2 with pBMP-6 or pBMP-7) was used to create BMP-2/6 and BM-2/7 heterodimers. Formation and secretion of the heterodimer proteins was validated by sandwich enzyme-linked immunosorbent assay (ELISA). Produced BMPs and heterodimers were biologically active, as confirmed by differentiation of reporter cells and MSCs. To assess bone formation, transfected MSCs were seeded on to ceramic scaffolds and implanted subcutaneously into nude mice. Bone formation was significantly enhanced in the pBMP-2/6 condition and a trend for more bone formation was observed in the pBMP-2/7 and pBMP-6 homodimer condition. No bone was found in the pBMP-2, pBMP-7 or control condition. In conclusion, simultaneous delivery of pBMP-2 with pBMP-6 or -7 resulted in the production of heterodimers that were beneficial for bone formation as compared to BMP homodimers. Combination of BMP sequences could reduce the need for high BMP protein dosages and might enhance prolonged availability of the growth factors.


Assuntos
Proteínas Morfogenéticas Ósseas/genética , Técnicas de Transferência de Genes , Osteogênese , Multimerização Proteica , Animais , Proteínas Morfogenéticas Ósseas/metabolismo , Diferenciação Celular/efeitos dos fármacos , Sobrevivência Celular , Feminino , Terapia Genética , Cabras , Humanos , Células-Tronco Mesenquimais/metabolismo , Camundongos Nus , Próteses e Implantes , Transfecção , Transgenes
2.
Eur Cell Mater ; 33: 211-226, 2017 02 27.
Artigo em Inglês | MEDLINE | ID: mdl-28266689

RESUMO

To explore the influence of inflammatory processes on bone formation, we applied a new in vivo screening model. Confined biological pockets were first created in rabbits as a response to implanted bone cement discs. These biomembrane pockets were subsequently used to study the effects of inflammatory stimuli on ectopic bone formation within biphasic calcium phosphate (BCP) constructs loaded with TNF-α, lipopolysaccharide (LPS) or lipoteichoic acid (LTA), all with or without bone morphogenetic protein (BMP)-2. Analysis of bone formation after 12 weeks demonstrated that the inflammatory mediators were not bone-inductive in combination with the BCP alone, but inhibited or enhanced BMP-induced bone formation. LPS was associated with a strong inhibition of bone formation by BMP-2, while LTA and TNF-α showed a positive interaction with BMP-2. Since the biomembrane pockets did not interfere with bone formation and prevented the leakage of pro-inflammatory compounds to the surrounding tissue, the biomembrane model can be used for in vivo approaches to study local inflammation in conjunction with new bone formation. Using this model, it was shown that the modulation of the inflammatory response could be beneficial or detrimental to the subsequent bone formation process. The co-delivery of inflammatory factors and bone-related growth factors should be further explored as a strategy to enhance the bone-forming efficacy of bone substitutes.


Assuntos
Inflamação/patologia , Osteogênese , Animais , Proteína Morfogenética Óssea 2/farmacologia , Fosfatos de Cálcio/farmacologia , Agregação Celular/efeitos dos fármacos , Corantes Fluorescentes/metabolismo , Implantes Experimentais , Lipopolissacarídeos/farmacologia , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Masculino , Osteogênese/efeitos dos fármacos , Coelhos , Ratos , Tela Subcutânea/efeitos dos fármacos , Tela Subcutânea/patologia
3.
Osteoarthritis Cartilage ; 22(11): 1910-7, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25151084

RESUMO

OBJECTIVE: Interactions between chondrocytes and their native pericellular matrix provide optimal circumstances for regeneration of cartilage. However, cartilage diseases such as osteoarthritis change the pericellular matrix, causing doubt to them as a cell source for autologous cell therapy. METHODS: Chondrons and chondrocytes were isolated from stifle joints of goats in which cartilage damage was surgically induced in the right knee. After 4 weeks of regeneration culture, DNA content and proteoglycan and collagen content and release were determined. RESULTS: The cartilage regenerated by chondrons isolated from the damaged joint contained less proteoglycans and collagen compared to chondrons from the same harvest site in the nonoperated knee (P < 0.01). Besides, chondrons still reflected whether they were isolated from a damaged joint, even if they where isolated from the opposing or adjacent condyle. Although chondrocytes did not reflect this diseased status of the joint, chondrons always outperformed chondrocytes, even when isolated from the damaged joints (P < 0.0001). Besides increased cartilage production, the chondrons showed less collagenase activity compared to the chondrocytes. CONCLUSION: Chondrons still outperform chondrocytes when they were isolated from a damaged joint and they might be a superior cell source for articular cartilage repair and cell-induced cartilage formation.


Assuntos
Regeneração Óssea , Cartilagem Articular/fisiologia , Terapia Baseada em Transplante de Células e Tecidos/métodos , Condrócitos/transplante , Articulação do Joelho/patologia , Osteoartrite do Joelho/patologia , Animais , Células Cultivadas , Modelos Animais de Doenças , Feminino , Cabras , Osteoartrite do Joelho/terapia
4.
Osteoarthritis Cartilage ; 22(1): 145-53, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24269634

RESUMO

OBJECTIVE: Hsa-miR-148a expression is decreased in Osteoarthritis (OA) cartilage, but its functional role in cartilage has never been studied. Therefore, our aim was to investigate the effects of overexpressing hsa-miR-148a on cartilage metabolism of OA chondrocytes. DESIGN: OA chondrocytes were transfected with a miRNA precursor for hsa-miR-148a or a miRNA precursor negative control. After 3, 7, 14 and 21 days, real-time PCR was performed to examine gene expression levels of aggrecan (ACAN), type I, II, and X collagen (COL1A1, COL2A1, COl10A1), matrix metallopeptidase 13 (MMP13), a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) and the serpin peptidase inhibitor, clade H (heat shock protein 47), member 1 (SERPINH1). After 3 weeks, DNA content and proteoglycan and collagen content and release were determined. Type II collagen was analyzed at the protein level by Western blot. RESULTS: Overexpression of hsa-miR-148a had no effect on ACAN, COL1A1 and SERPINH1 gene expression, but increased COL2A1 and decreased COL10A1, MMP13 and ADAMTS5 gene expression. Luciferase reporter assay confirmed direct interaction of miR-148a and COL10A1, MMP13 and ADAMTS5. The matrix deposited by the miR-148a overexpressing cells contained more proteoglycans and collagen, in particular type II collagen. Proteoglycan and collagen release into the culture medium was inhibited, but total collagen production was increased. CONCLUSION: Overexpression of hsa-miR-148a inhibits hypertrophic differentiation and increases the production and deposition of type II collagen by OA chondrocytes, which is accompanied by an increased retention of proteoglycans. Hsa-miR-148a might be a potential disease-modifying compound in OA, as it promotes hyaline cartilage production.


Assuntos
Cartilagem Articular/patologia , Condrócitos/metabolismo , MicroRNAs/fisiologia , Osteoartrite do Joelho/metabolismo , Proteínas ADAM/biossíntese , Proteínas ADAM/genética , Proteína ADAMTS5 , Idoso , Idoso de 80 Anos ou mais , Cartilagem Articular/metabolismo , Células Cultivadas , Condrócitos/patologia , Colágeno Tipo II/biossíntese , Colágeno Tipo II/genética , Colágeno Tipo X/biossíntese , Colágeno Tipo X/genética , Feminino , Regulação da Expressão Gênica , Humanos , Masculino , Metaloproteinase 13 da Matriz/biossíntese , Metaloproteinase 13 da Matriz/genética , MicroRNAs/biossíntese , Pessoa de Meia-Idade , Osteoartrite do Joelho/genética , Osteoartrite do Joelho/patologia , Proteoglicanas/metabolismo , RNA Mensageiro/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...